Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 18, 2007, Pages 3205-3215

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

observation; papillary microcarcinoma; prognosis; surgery; thyroid

Indexed keywords

THYROTROPIN; THYROXINE;

BLOOD; HUMAN; INCIDENTAL FINDING; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; REVIEW; THYROID TUMOR; THYROIDECTOMY; TUMOR RECURRENCE;

CARCINOMA, PAPILLARY; HUMANS; INCIDENTAL FINDINGS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE;

EID: 40949115590     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.8.18.3205     Document Type: Review

References (68)

1. SOBIN LH, WITTEKIND CH (Ed.): UICC: TNM Classifi cation of Malignant Tumors, 6th Edition. Wiley-Liss, New York, NY, USA ( 2002).
2. YOKOZAWA T, MIYAUCHI A, KUMA K, SUGAWARA M: Accurate and simple method of diagnosing thyroid nodules by the modifi ed technique of ultrasound-guided fi ne needle aspiration biopsy. Thyroid (1995) 5:141-145.
3. HARACH HR, FRANSSILA KO, WASENIUS VM: Occult papillary carcinoma of the thyroid: a "normal" fi nding in Finland. A systematic autopsy study. Cancer (1985) 56:531-538.
4. FUKUNAGA FH, YATANI R: Geographic pathology of occult thyroid carcinomas. Cancer (1975) 36:1095-1099.
5. SAMSON RJ: Prevalence and signifi cant of occult thyroid cancer. In: Radiation-Associated Thyriod Carcinoma Degroot LJ (Ed.), Grune & Stratton, New York, NY, USA ( 1977): 137-153.
6. NISHIYAMA RH, LUDWIG GK, THOMPSON NW: The prevalence of small papillary thyroid carcinomas in 100 consecutive necropsies in an American poulation. In: Radiation-Associated Thyroid Carcinoma . Degroot LJ (Ed.), Grune & Stratton, New York, NY, USA (1977): 123-135.
7. THORVALDSSON SE, TULINIUS H, BJORNSSON J et al : Latent thyroid carcinoma in Iceland at autopsy. Pathol. Res. Pract. (1992) 188:747-750.
8. LANG W, BORRUSCH G, BAUER L: Occult carcinomas of the thyroid. Am. J. Clin. Pathol. (1988) 90:72-76.
9. YAMAMOTO Y, TOSHIHARU M, IZUMI K et al. : Occult papillary carcinoma of the thyroid. Cancer (1990) 65:1173-1179.
10. ITO Y, MIYAUCHI A: Therapeutic strategies for papillary microcarcinoma of the thyroid. Curr. Cancer Ther. Rev. (2005) 1:19-25 (Review).
11. TAKEBE K, DATE M, YAMAMOTO Y, OGINO T, TAKEUCHI Y: Mass screening for thyroid cancer with ultrasonography. Karkinos (1994) 7:309-317 (in Japanese).
12. DAVIES L, WELCH HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 295:2164-2167.
13. SAMPSON RJ, KEY CR: Smallest forms of papillary carcinoma of the thyroid. Arch. Pathol. (1970) 91:334-339.
14. IIDA F, SUGENOYA A, MURAMATSU A: Clinical and pathologic properties of small differentiated carcinomas of the thyroid gland. World J. Surg. (1991) 15:511-515.
15. HAY ID, GRANT CS, VAN HEERDEN JA, GOELLNER JR, EBERSOLD JR, BERGSTRALH EJ: Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 112:1139-1147.
16. RODRIGUEZ JM, MORENO A, PARRILA P et al : Papillary thyroid microcarcinoma: clinical study and prognosis. Eur. J. Surg. (1997) 163:255-259.
17. LIN KD, LINJD, HUANG MJ et al: Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg (1997) 82:378-381.
18. RASSAEL H, THOMPSON LDR, HEFFESS CS: A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathological correlation of 90 cases. Eur. Arch. Otorhinolaryngol (1998) 255:462-467.
19. SUGITANI I, FUMIMOTO Y Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. (1999)46:209-216.
20. FALVO L, D'ERCOLE C, SORRENTI S et al : Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological sybtype. Eur. J. Surg. (2002) 168:28-32.
21. WADA N, DUH QY, SUGINO K et al: Lymph node metastasis from 259 papillary thyroid microcarcinomas. Ann. Surg. (2003) 237:399-407.
22. CHOW SM, LAWS CK, CHAN JK et al.: Papillary microcarcinoma of the thyroid-prognostic signifi cance of lymph node metastasis and multifocally Cancer (2003) 98:31-40.
23. ITO Y, TOMODA C, URUNO T et al: Papillary microcarcinoma of the thyroid: how should it be treated? World J. Surg. (2004) 28:1115-1121.
24. ITO Y, URUNO R, NAKANO K et al.: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 13:381-388.
25. MIYAUCHI A, MATSUSAKA K, KIHARA M et al : The role of ansa-to-recurrent-laryngeal nerve anastomosis in operations for thyroid cancer. Eur. J. Surg. (1998) 164:927-933.
26. MIYAUCHI A, YOKOZAWA T, KOBAYASHI K, HIRAI K, MATSUZUKA F, KUMA K: Opposite ansa cervicalis to recurrent laryngeal nerve anastomosis to restore phonation in patients with advanced thyroid cancer. Eur. J. Surg. (2001) 167:540-541.
27. ANTONELLI A, MICOLLI P, FERDEGHINI M et al : Role of neck ultrsonography in follow-up of patients operated on for different thyroid cancer. Thyroid (1995) 5:25-29.
28. URUNO T, MIYAUCHI A, SHIMIZU K: Usefulness of thyroglobulin measurement in fi ne-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J. Surg. (2005) 29:483-485.
29. ITO Y, MIYAUCHI A: A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat. Clin. Pract. Endocrinol. Metab. (2007) 3:240-248.
30. ITO Y, MIYAUCHI A: Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefi ts, and risks. World J. Surg. (2007) 2007(5):905-915.
31. SUGENOYA A, ASANUMA K, SHINGU K et al : Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery (1993) 113:541-544.
32. MACHENS A, HINZE R, THOMUSCH O, DRALLE H: Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J. Surg. (2002) 26:22-28.
33. DRALLE H, GIMM O: Lymphadenektomie beim schilddrusencarcinom. Chirurg (1996) 67:788-806 (in German).
34. MARTENSON H, TERINS J: Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch. Surg. (1985) 120:475-482.
35. SCHEUMANN GF, SEELIGER H, MUSHOLT TF et al.: Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur. J. Surg. (1996) 162:677-684.
36. ITO Y, TOMODA C, URUNO T et al.: Clinical signifi cance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J. Surg. (2006) 30:91-99.
37. ITO Y, JIKUZONO T, HIGASHIYAMA T et al.: Clinical signifi cance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. (2006) 30:1821-1828.
38. NOGUCHI S, MURAKAMI N, YAMASHITA H, TADA M, KAWAMOTO H: Papillary thyroid carcinoma. Modifi ed radical neck dissection improves prognosis. Arch. Surg. (1998) 133:276-280.
39. KUPFERMAN ME, PATTERSON DM, MANDEL SJ, LIVOLSI V, WEBER RS: Safety of modifi ed radical neck dissection for differentiated thyroid carcinoma. Laryngoscope (2004) 114:403-406.
40. SIMON D, GORETZKI PE, WITTE J, ROHER HD: Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J. Surg. (1996) 20:860-866.
41. ITO Y, TINIDA C, URUNO T et al.: Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J. Surg. (2004) 28:498-501.
42. ROTI E, ROSSI R, TRASFORINI G et al. : Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrnol. Metab. (2006) 91:2171-2178.
43. PELLEGRITI G, SCOLLO C, LUMERA G, REGALBUTO C, VIGNERI R, BELFIORE A: Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J. Clin. Endocrinol. Metab. (2004) 89:3713-3720.
44. YAMASHITA H, NOGUCHI S, MURAKAMI N et al.: Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer (1998) 86:842-849.
45. TORLONTANO M, CROCETTI U, AUGELLO G et al.: Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131 I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J. Clin. Endocrinol. Metab. (2006) 91:60-63.
46. PACINI F, SCHLUMBERGER M, HARMER C et al. : Post-surgical use of radioiodine ( 131 I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur. J. Endocrinol. (2005) 153:651-659.
47. MAZAFERRI EL: Managing small thyroid cancers. JAMA (2006) 295:2179-2182.
48. ITO Y, MIYAUCHI A, JIKUZONO T et al. : Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; validity of UICC/AJCC TNM classifi cation and stage grouping. World J. Surg. (2007) 31:838-848.
49. MAZZAFERRI EL, YOUNG RL: Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. (1994) 97:418-428.
50. SALVESEN H, NJOLSTAD PR, AKSLEN LA et al. : Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur. J. Surg. (1992) 158:583-589.
51. AKSLEN LA, MYKING AO, SALVESEN H et al.: Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur. J. Cancer (1992) 29:44-51.
52. SCHEUMANN GF, GIMM O, WEGENER G et al.: Prognostic signifi cance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J. Surg. (1994) 18:559-567.
53. BOTTGERT, KUPP J, GABBERT HE et al. : Prognostically relevant factors in papillary thyroid cancer. Med. Klin. (1991) 86:76-82.
54. SHAHA AR, SHAH JP, LOREE TR: Risk group stratifi cation and prognostic factors in papillary carcinoma of thyroid. Ann. Surg. Oncol. (1996) 3:534-538.
55. ITO Y, URUNO T, TAKAMURA Y et al.: Papillary microcarcinoma of the thyroid with preoperatively detectable lymph node metastasis show signifi cantly higher aggressive characteristics on immunohistochemical examination. Oncology (2005) 68:87-96.
56. ITO Y, TOMODA C, URUNO T et al.: Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45. Surg. Today (2006) 36:12-18.
57. ITO Y, KOBAYASHI K,TOMODA C et al.: Ill-defi ned edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarinoma. World J. Surg. (2005) 29:1007-1012.
58. SUGITANI I, YANAGISAWA A, SHIMIZU A, KATO M, FUJIMOTO Y et al. : Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J. Surg. (1998) 22:731-737.
59. MAZAFFERI EL, JHIANG SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. (1994) 97:418-428.
60. PUJOL P, DAURES JP, NSAKALA N et al. : Degree of thyrotropin suppression as a prognosis determinant in differentiated thyroid cancer. J. Clin. Endocrinol. Metab. (1996) 81:4318-4323.
61. COOPER DS, SPECKER B, HO M et al.: Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National thyroid cancer treatment cooperative registry. Thyroid (1999) 8:737-744.
62. HUNG W, SARLIS NJ: Current controversies in the management of pediatric patients with well-differentiated non-medullary thyroid cancer: a review. Thyroid (2002) 12:683-702.
63. DULGEROFF AJ, HERSHMAN JM: Medical therapy for differentiated thyroid carcinoma. Endocrinol. Rev. (1994) 15:500-515.
64. SAVIN CT, GELLER A WOLF PA et al.: Low serum thyrotropin concentrations as a risk factor for atrial fi brillation in older persons. N. Engl. J. Med. (1994) 331:1249-1252.
65. NAMBA H, RUBIN SA, FAGIN JA: Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol. (1990) 4:1474-1479.
66. GARCIA-ROSTAN G, ZHAO H, CAMP RL et al. : Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J. Clin. Oncol. (2003) 21:3226-3235.
67. XING M, WESTRA WH, TUFANO RP et al.: BRAF mutation predicts a poorer clinical prognosis for papillary cancer. J. Clin. Endoclinol. Metab. (2005) 90:6373-6379.
68. KIM TY, KIM WB, SONG JY et al.: The BRAFV600E is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin. Endocrinol. (2005) 63:588-593.